Sichuan Huiyu Pharmaceutical Hits Day Low Amid Price Pressure at CNY 10.72

Sichuan Huiyu Pharmaceutical Co., Ltd. experienced significant volatility today, with the stock hitting an intraday low of CNY 10.72. The company has reported a notable decline of 32.9% in its stock price, contrasting sharply with the China Shanghai Composite, which saw a modest gain of 0.4% on the same day. Over the past week, Sichuan Huiyu's performance has been similarly challenging, with a decrease of 33.07%. The one-month performance reflects a steep decline of 45.67%, while the year-to-date performance shows a drop of 38.67%. In the last year, the stock has underperformed the market, generating a return of just 6.63% compared to the China Shanghai Composite's 21.28%. Financial metrics indicate ongoing difficulties for the company, with net sales declining at an annual rate of 15.85% over the past five years. Recent half-year results show net sales at CNY 502.7 million, down 17.49%, and a net profit of CNY 53.87 million, down 31.32%. The return on capital employed (ROCE) has also reached a low of 1.24%, highlighting the company's current market position within the pharmaceuticals and biotechnology sector.